127 related articles for article (PubMed ID: 12172502)
21. Antitumor activity of novel octalactin A analogs in murine leukemia cells in vitro.
Perchellet JP; Perchellet EM; Newell SW; Freeman JA; Ladesich JB; Jeong Y; Sato N; Buszek K
Anticancer Res; 1998; 18(1A):97-106. PubMed ID: 9568062
[TBL] [Abstract][Full Text] [Related]
22. Modulation by adriamycin, daunomycin, verapamil, and trifluoperazine of the biochemical processes linked to mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
Satyamoorthy K; Perchellet JP
Cancer Res; 1989 Oct; 49(19):5364-70. PubMed ID: 2475247
[TBL] [Abstract][Full Text] [Related]
23. Increased gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide.
Eymin B; Dubrez L; Allouche M; Solary E
Cancer Res; 1997 Feb; 57(4):686-95. PubMed ID: 9044846
[TBL] [Abstract][Full Text] [Related]
24. Characterization and modulation of drug transport kinetics in K562 c1.6 daunorubicin-resistant cell line.
Jiang XR; Macey MG; Collins PW; Newland AC
Br J Haematol; 1994 Mar; 86(3):547-54. PubMed ID: 8043436
[TBL] [Abstract][Full Text] [Related]
25. Relationship between daunorubicin concentration and apoptosis induction in leukemic cells.
Masquelier M; Zhou QF; Gruber A; Vitols S
Biochem Pharmacol; 2004 Mar; 67(6):1047-56. PubMed ID: 15006541
[TBL] [Abstract][Full Text] [Related]
26. Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833.
Jiang XR; Kelsey SM; Wu YL; Newland AC
Br J Haematol; 1995 Jun; 90(2):375-83. PubMed ID: 7794760
[TBL] [Abstract][Full Text] [Related]
27. Effects of 3'-(4-morpholinyl)-3'-deaminodaunorubicin,3'- (4-methoxy-1-piperidinyl)-3'-deaminodaunorubicin and daunorubicin on nuclear and polysomal RNA synthesis in human colon carcinoma cells in vitro.
Johnston JB; Begleiter A; Glazer RI
Cancer Lett; 1986 Nov; 33(2):225-33. PubMed ID: 3791193
[TBL] [Abstract][Full Text] [Related]
28. New daunomycin-oligoarginine conjugates: synthesis, characterization, and effect on human leukemia and human hepatoma cells.
Miklán Z; Orbán E; Csík G; Schlosser G; Magyar A; Hudecz F
Biopolymers; 2009; 92(6):489-501. PubMed ID: 19521976
[TBL] [Abstract][Full Text] [Related]
29. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells.
Ling YH; Priebe W; Perez-Soler R
Cancer Res; 1993 Apr; 53(8):1845-52. PubMed ID: 8467504
[TBL] [Abstract][Full Text] [Related]
30. Comparison of mechanisms responsible for resistance to idarubicin and daunorubicin in multidrug resistant LoVo cell lines.
Toffoli G; Simone F; Gigante M; Boiocchi M
Biochem Pharmacol; 1994 Nov; 48(10):1871-81. PubMed ID: 7986198
[TBL] [Abstract][Full Text] [Related]
31. Induction of apoptosis by a novel copper-based anticancer compound, casiopeina II, in L1210 murine leukaemia and CH1 human ovarian carcinoma cells.
De Vizcaya-Ruiz A; Rivero-Muller A; Ruiz-Ramirez L; Kass GE; Kelland LR; Orr RM; Dobrota M
Toxicol In Vitro; 2000 Feb; 14(1):1-5. PubMed ID: 10699355
[TBL] [Abstract][Full Text] [Related]
32. Production of new anthracycline antibiotics by microbial 4-O-methylation using a specific daunorubicin-negative mutant.
Johdo O; Tone H; Okamoto R; Yoshimoto A; Takeuchi T
J Antibiot (Tokyo); 1992 Dec; 45(12):1837-47. PubMed ID: 1490874
[TBL] [Abstract][Full Text] [Related]
33. Antitumor activity of new N-substituted daunorubicin derivatives.
Mazerska Z; Woynarowska B; Stefanska B; Borowski E; Martelli S
Drugs Exp Clin Res; 1987; 13(6):345-51. PubMed ID: 3308387
[TBL] [Abstract][Full Text] [Related]
34. Bioactivity of synthetic 2-halo-3-aryl-4(3H)-quinazoliniminium halides in L1210 leukemia and SK-BR-3 mammary tumor cells in vitro.
Perchellet JP; Waters AM; Perchellet EM; Naganaboina VK; Chandra KL; Desper J; Rayat S
Anticancer Res; 2011 Jun; 31(6):2083-93. PubMed ID: 21737626
[TBL] [Abstract][Full Text] [Related]
35. [A fungus-derived novel nucleoside transport inhibitor potentiates the activity of antitumor drugs].
Su J; Zhen YS; Qi CQ; Chen WJ
Yao Xue Xue Bao; 1994; 29(9):656-61. PubMed ID: 7900536
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological and physicochemical properties of a new anthracycline with potent antileukemic activity.
Nafziger J; Auclair C; Florent JC; Guillosson JJ; Monneret C
Leuk Res; 1991; 15(8):709-13. PubMed ID: 1654481
[TBL] [Abstract][Full Text] [Related]
37. Denbinobin induces apoptosis in human lung adenocarcinoma cells via Akt inactivation, Bad activation, and mitochondrial dysfunction.
Kuo CT; Hsu MJ; Chen BC; Chen CC; Teng CM; Pan SL; Lin CH
Toxicol Lett; 2008 Feb; 177(1):48-58. PubMed ID: 18262737
[TBL] [Abstract][Full Text] [Related]
38. Serine protease inhibitors block neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin.
Mansat V; Bettaïeb A; Levade T; Laurent G; Jaffrézou JP
FASEB J; 1997 Jul; 11(8):695-702. PubMed ID: 9240970
[TBL] [Abstract][Full Text] [Related]
39. Cellular pharmacology of idarubicinol in multidrug-resistant LoVo cell lines.
Toffoli G; Corona G; Simone F; Gigante M; De Angeli S; Boiocchi M
Int J Cancer; 1996 Jul; 67(1):129-37. PubMed ID: 8690513
[TBL] [Abstract][Full Text] [Related]
40. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
